Literature DB >> 3170148

Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes.

M Murray, P Sarsfield, E Lawlor, S R McCann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170148     DOI: 10.1007/bf02949309

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  17 in total

Review 1.  The differentiation of myeloid leukaemia cells: new possibilities for therapy.

Authors:  L Sachs
Journal:  Br J Haematol       Date:  1978-12       Impact factor: 6.998

2.  Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly.

Authors:  A Worsley; G J Mufti; J A Copplestone; D G Oscier; T J Hamblin
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

3.  Low dose cytosine arabinoside used to induce remission in acute myelofibrosis.

Authors:  S Whitehead; C G Geary
Journal:  Br J Haematol       Date:  1984-10       Impact factor: 6.998

4.  The effect of low dose Ara-C in acute nonlymphoblastic leukaemias and atypical leukaemia.

Authors:  H Ishikura; H Sawada; T Okazaki; T Mochizuki; Y Izumi; M Yamagishi; H Uchino
Journal:  Br J Haematol       Date:  1984-09       Impact factor: 6.998

5.  Causes of initial remission induction failure in acute myelogenous leukemia.

Authors:  E H Estey; M J Keating; K B McCredie; G P Bodey; E J Freireich
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

6.  Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.

Authors:  H Tilly; S Castaigne; D Bordessoule; F Sigaux; M T Daniel; M Monconduit; L Degos
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

7.  Leukemia in Rochester (NY). A 17-year experience with an analysis of the role of cooperative group (ECOG) participation.

Authors:  L Boros; C Chuang; F O Butler; J M Bennett
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

8.  Low dose cytosine arabinoside: partial remission of acute myeloid leukaemia without evidence of differentiation induction.

Authors:  M Leyden; A Manoharan; A Boyd; Z M Cheng; J Sullivan
Journal:  Br J Haematol       Date:  1984-06       Impact factor: 6.998

9.  Acute myeloblastic leukemia in elderly patients: treatment and prognostic factors.

Authors:  J Reiffers; F Raynal; A Broustet
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

10.  Effect of chemotherapy for the dysmyelopoietic syndrome.

Authors:  J O Armitage; F R Dick; S W Needleman; C P Burns
Journal:  Cancer Treat Rep       Date:  1981 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.